Schizophrenia, Cancer and Obstetric Complications in an Evolutionary Perspective-An Empirically Based Hypothesis

키워드

참고문헌 (206)

1. Eun-Jeong Joo, "AKT1 Gene Polymorphisms and Obstetric Complications in the Patients with Schizophrenia", PSYCHIATRY INVESTIGATION, 6(2), pp.102~107 (2009), 대한신경정신의학회
2. Kalkman HO, "The role of the phosphatidylinositide", Pharmacol Ther, 110, pp.117~134 (2006)
3. Preti A, "Reduced risk of cancer in schizophrenia: a role for obstetric complications", Acta Psychiatr Scand, 118, pp.251~253 (2008)
4. Sacker A, "Antecedents of schizophrenia and affective illness. Obstetric complications", Br J Psychiatry, 166, pp.734~741 (1995)
5. Cannon M, "Obstetric complications and schizophrenia: historical and meta-analytic review", Am J Psychiatry, 159, pp.1080~1092 (2002)
6. Lichtermann D, "Incidence of cancer among persons with schizophrenia and their relatives", Arch Gen Psychiatry, 58, pp.573~578 (2001)
7. Catts VS, "Cancer incidence in patients with schizophrenia and their first-degree relatives-a meta-analysis", Acta Psychiatr Scand, 117, pp.323~336 (2008)
8. Wilson DR, "The Evolutionary Epidemiology of Mania & Depression" (2008), Mellen Press
9. Stevens A, "Evolutionary psychiatry. A New Beginning" (1996), Routledge
10. Wilson DR, "Evolutionary epidemiology", Acta Biotheor, 40, pp.87~89 (1992)
11. Harrison G, "Recovery from psychotic illness: a 15- and 25-year international follow- up study", Br J Psychiatry, 178, pp.506~517 (2001)
12. Leucht S, "Physical illness and schizophrenia: a review of the literature", Acta Psychiatr Scand, 116, pp.317~333 (2007)
13. Saha S, "A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time", Arch Gen Psychiatry, 64, pp.1123~1131 (2007)
14. Lauber C, "Family burden during exacerbation of schizophrenia: quantification and determinants of additional costs", Int J Soc Psychiatry, 51, pp.259~264 (2005)
15. Knapp M, "The global costs of schizophrenia", Schizophr Bull, 30, pp.279~293 (2004)
16. McGrath J, "Schizophrenia: a concise overview of incidence, prevalence, and mortality", Epidemiol Rev, 30, pp.67~76 (2008)
17. Sullivan, PF, "The genetics of schizophrenia", PLoS Med, 2, pp.e212~ (2005)
18. Tienari P, "Genotype- environment interaction in schizophrenia-spectrum disorder. Longterm follow-up study of Finnish adoptees", Br J Psychiatry, 184, pp.216~222 (2004)
19. Cannon TD, "The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study", Arch Gen Psychiatry, 55, pp.67~74 (1998)
20. Cardno AG, "Twin studies of schizophrenia: from bowand- arrow concordances to star wars Mx and functional genomics", Am J Med Genet, 97, pp.12~17 (2000)
21. Gottesman II, "Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia", Schizophr Res, 51, pp.93~102 (2001)
22. Kendler KS, "The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives", Arch Gen Psychiatry, 50, pp.527~540 (1993)
23. Mortensen PB, "Effects of family history and place and season of birth on the risk of schizophrenia", N Engl J Med, 340, pp.603~608 (1999)
24. Tienari P, "Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia", Am J Psychiatry, 160, pp.1587~1594 (2003)
25. Keshavan MS, "Schizophrenia, “just the facts”: what we know in 2008 Part 3: neurobiology", Schizophr Res, 106, pp.89~107 (2008)
26. Boyle M, "Schizophrenia: A Scientific Delusion" (2002), Routledge
27. Craddock N, "The beginning of the end for the Kraepelinian dichotomy", Br J Psychiatry, 186, pp.364~366 (2005)
28. Peralta V, "A dimensional and categorical architecture for the classification of psychotic disorders", World Psychiatry, 6, pp.100~101 (2007)
29. Crow TJ, "Craddock & Owen vs Kraepelin: 85 years late, mesmerised by “polygenes”", Schizophr Res, 103, pp.156~160 (2008)
30. Jablensky A, "Subtyping schizophrenia: implications for genetic research", Mol Psychiatry, 11, pp.815~836 (2006)
31. Hiroeh U, "Deaths from natural causes in people with mental illness: a cohort study", J Psychosom Res, 64, pp.275~283 (2008)
32. Harris EC, "Excess mortality of mental disorder", Br J Psychiatry, 173, pp.11~53 (1998)
33. Palmer BA, "The lifetime risk of suicide in schizophrenia: a reexamination", Arch Gen Psychiatry, 62, pp.247~253 (2005)
34. Cividini A, "Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk", J Hepatol, 27, pp.455~463 (1997)
35. Ohta Y, "The epidemiological study of physical morbidity in schizophrenics--2. Association between schizophrenia and incidence of tuberculosis", Jpn J Psychiatry Neurol, 42, pp.41~47 (1988)
36. Wainberg ML, "HIV and hepatitis C in patients with schizophrenia, in Medical illness and schizophrenia", pp.115~140 (2003), American Psychiatric Publishing Inc
37. Filik R, "The cardiovascular and respiratory health of people with schizophrenia", Acta Psychiatr Scand, 113, pp.298~305 (2006)
38. Allison DB, "Antipsychotic-induced weight gain: a comprehensive research synthesis", Am J Psychiatry, 156, pp.1686~1696 (1999)
39. Heiskanen T, "Metabolic syndrome in patients with schizophrenia", J Clin Psychiatry, 64, pp.575~579 (2003)
40. Newcomer JW, "Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia", Arch Gen Psychiatry, 59, pp.337~345 (2002)
41. Goff DC, "A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls", Schizophr Res, 80, pp.45~53 (2005)
42. McDermott S, "Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care", Community Ment Health J, 41, pp.747~755 (2005)
43. Friedlander AH, "The psychopathology, medical management and dental implications of schizophrenia", Am Dent Assoc, 133, pp.603~625 (2002)
44. McCreadie RG, "The dental health of people with schizophrenia", Acta Psychiatr Scand, 110, pp.306~310 (2004)
45. McCreadie RG, "Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study", Br J Psychiatry, 183, pp.534~539 (2003)
46. Nosé M, "How often do patients with psychosis fail to adhere to treatment programmes? A systematic review", Psychol Med, 33, pp.1149~1160 (2003)
47. Newcomer JW, "Antipsychotic medications: metabolic and cardiovascular risk", J Clin Psychiatry, 68(4), pp.8~13 (2007)
48. Østbye T, "Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study", Pharmacoepidemiol Drug Saf, 14, pp.407~415 (2005)
49. Fontaine KR, "Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate", Psychiatry Res, 101, pp.277~288 (2001)
50. Barak Y, "Reduced cancer incidence among patients with schizophrenia", Cancer, 104, pp.2817~2821 (2005)
51. Cohen M, "The association between schizophrenia and cancer: a population-based mortality study", Schizophr Res, 57, pp.139~146 (2002)
52. Dalton SO, "Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993", Schizophr Res, 75, pp.315~324 (2005)
53. Grinshpoon A, "Cancer in schizophrenia: is the risk higher or lower", Schizophr Res, 73, pp.333~341 (2005)
54. Hamilton WD, "The evolution of altruistic behaviour", Am Nat, 97, pp.354~356 (1963)
55. Hamilton WD, "The genetical evolution of social behaviour", J Theor Biol, 7, pp.1~52 (1964)
56. Lane A, "Reproductive behaviour in schizophrenia relative to other mental disorders: evidence for increased fertility in men despite decreased marital rate", Acta Psychiatr Scand, 91, pp.222~228 (1995)
57. Srinivasan TN, "Fertility and schizophrenia: evidence for increased fertility in the relatives of schizophrenic patients", Acta Psychiatr Scand, 96, pp.260~264 (1997)
58. Erlenmeyer-Kimling L, "Changes in fertility rates of schizophrenic patients in New York", Am J Psychiatry, 125, pp.916~927 (1969)
59. Howard LM, "The general fertility rate in women with psychotic disorders", Am J Psychiatry, 159, pp.991~997 (2002)
60. Sullivan RJ, "Natural selection and schizophrenia", Behav Brain Sci, 27, pp.865~866 (2004)
61. Haukka J, "Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland", Am J Psychiatry, 160, pp.460~463 (2003)
62. Svensson AC, "Fertility of firstdegree relatives of patients with schizophrenia: a three generation perspective", Schizophr Res, 91, pp.238~245 (2007)
63. de Girolamo G, "The current state of mental health care in Italy: problems, perspectives, and lessons to learn", Eur Arch Psychiatry Clin Neurosci, 257, pp.83~91 (2007)
64. Huxley J, "Schizophrenia as a genetic morphism", Nature, 204, pp.220~221 (1964)
65. Odegaard F, "Mortality in Norwegian mental hospitals from 1916 to 1933", Acta Psychiatr Scand, 11, pp.323~356 (1936)
66. Commissioners in Lunacy for England and Wales, , HMSO, ~ (1909)
67. Jablensky A, "Schizophrenia and cancer: is there a need to invoke a protective gene", Arch Gen Psychiatry, 58, pp.579~580 (2001)
68. Gulbinat W, "Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries", Br J Psychiatry Suppl, 18, pp.75~83 (1992)
69. de Leon J, "A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors", Schizophr Res, 76, pp.135~157 (2005)
70. Lohr JB, "Smoking and schizophrenia", Schizophr Res, 8, pp.93~102 (1992)
71. Harris JE, "Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8", BMJ, 328, pp.72~ (2004)
72. Brown S, "The unhealthy lifestyle of people with schizophrenia", Psychol Med, 29, pp.697~701 (1999)
73. Cargiulo T, "Understanding the health impact of alcohol dependence", Am J Health Syst Pharm, 64, pp.S5~S11 (2007)
74. Cradock-O’Leary J, "Use of general medical services by VA patients with psychiatric disorders", Psychiatr Serv, 53, pp.874~878 (2002)
75. Band PR, "Identification of occupational cancer risks in British Columbia. A population- based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors", J Occup Environ Med, 42, pp.284~310 (2000)
76. Band PR, "Identification of occupational cancer risks in British Columbia: a population-based case-control study of 1129 cases of bladder cancer", J Occup Environ Med, 47, pp.854~858 (2005)
77. Csatary LK, "Chlorpromazines and cancer", Lancet, 2, pp.338~339 (1972)
78. Driscoll JS, "Psychotropic drugs as potential antitumor agents: a selective screening study", Cancer Treat Rep, 62, pp.45~74 (1978)
79. Dalton SO, "Cancer risk among users of neuroleptic medication: a population-based cohort study", Br J Cancer, 95, pp.934~939 (2006)
80. Mothlagh PB, "Chlorpromazine enhancement of epirubicin cytotoxicity in vitro: effects on plasma membrane and DNA damage", Drug Metabol Drug Interact, 10, pp.169~176 (1992)
81. Torrey EF, "Prostate cancer and schizophrenia", Urology, 68, pp.1280~1283 (2006)
82. Steiner MS, "Selective estrogen receptor modulators for the chemoprevention of prostate cancer", Urology, 57, pp.68~72 (2001)
83. Mortimer AM, "Relationship between estrogen and schizophrenia", Expert Rev Neurother, 7, pp.45~55 (2007)
84. Halbreich U, "Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects", Psychoneuroendocrinology, 28, pp.53~67 (2003)
85. Jeste DV, "Medical comorbidity in schizophrenia", Schizophr Bull, 22, pp.413~430 (1996)
86. Levav I, "Cancer risk among parents and siblings of patients with schizophrenia", Br J Psychiatry, 190, pp.156~161 (2007)
87. Dalton SO, "Risk for cancer in parents of patients with schizophrenia", Am J Psychiatry, 161, pp.903~908 (2004)
88. Dong C, "Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families", Int J Cancer, 92, pp.144~150 (2001)
89. Imsland AK, "Genetic epidemiologic aspects of gastric cancer in Iceland", J Am Coll Surg, 195, pp.181~187 (2002)
90. Matikaine MP, "Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland", Cancer Causes Control, 12, pp.223~230 (2001)
91. Kerber RA, "A cohort study of cancer risk in relation to family histories of cancer in the Utah population database", Cancer, 103, pp.1906~1915 (2005)
92. Li X, "Inherited predisposition to early onset lung cancer according to histological type", Int J Cancer, 112, pp.451~457 (2004)
93. Lynch HT, "Genetic susceptibility to non-polyposis colorectal cancer", J Med Genet, 36, pp.801~818 (1999)
94. Lynch HT, "Hereditary colorectal cancer", N Engl J Med, 348, pp.919~932 (2003)
95. Lewis DA, "Schizophrenia as a disorder of neurodevelopment", Annu Rev Neurosci, 25, pp.409~432 (2002)
96. Portin P, "A critical review of genetic studies of schizophrenia. I. Epidemiological and brain studies", Acta Psychiatr Scand, 95, pp.1~5 (1997)
97. Abel KM, "Schizophrenia, cancer and imprinting: early nutritional influences", Br J Psychiatry, 188, pp.394~ (2006)
98. Tsankova N, "Epigenetic regulation in psychiatric disorders", Nat Rev Neurosci, 8, pp.355~367 (2007)
99. Owen MJ, "Schizophrenia: genes at last", Trends Genet, 21, pp.518~525 (2005)
100. DeLisi L, "A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder", Am J Psychiatry, 159, pp.803~812 (2002)
101. Maier W, "Clinical impact of recently detected susceptibility genes for schizophrenia", Dialogues Clin Neurosci, 8, pp.79~84 (2006)
102. Foster HD, "Schizophrenia and cancer: the adrenochrome balanced morphism", Med Hypotheses, 62, pp.415~419 (2004)
103. Keller MC, "Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best", Behav Brain Sci, 29, pp.385~452 (2006)
104. Mittal VA, "Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications", Schizophr Bull, 34, pp.1083~1094 (2008)
105. Preti A, "Genetics, perinatal insult, and schizophrenia: the mechanism underlying an increased prevalence of perinatal complications among individuals with a diagnosis of schizophrenia", Curr Psychiatry Rev, 1, pp.139~150 (2005)
106. Boksa P, "Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders", Neurosci Biobehav Rev, 27, pp.91~101 (2003)
107. Engel SA, "Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms", Epidemiology, 16, pp.469~477 (2005)
108. Fatemi SH, "Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice", Mol Psychiatry, 4, pp.145~154 (1999)
109. Geddes JR, "Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis", Schizophr Bull, 25, pp.413~423 (1999)
110. Kipnis J, "Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response", J Neurosci, 21, pp.4564~4571 (2001)
111. Friedman EA, "Labor and Delivery Impact on Offspring" (1987), PSG Publication
112. Paneth N, "Cerebral palsy and mental retardation in relation to indicators of perinatal asphyxia. An epidemiologic overview", Am J Obstet Gynecol, 147, pp.960~966 (1983)
113. Clarke MC, "The role of obstetric events in schizophrenia", Schizophr Bull, 32, pp.3~8 (2006)
114. Isohanni M, "Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study", World Psychiatry, 5, pp.168~171 (2006)
115. Hollister JM, "Rhesus incompatibility as a risk factor for schizophrenia in male adults", Arch Gen Psychiatry, 53, pp.19~24 (1996)
116. Palmer CG, "RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility", Am J Hum Genet, 71, pp.1312~1319 (2002)
117. Walshe M, "Obstetric complications in patients with schizophrenia and their unaffected siblings", Eur Psychiatry, 20, pp.28~34 (2005)
118. Preti A, "Risk for obstetric complications and schizophrenia", Psychiatry Res, 96, pp.127~139 (2000)
119. Ohara K, "Obstetric complications in siblings of Japanese schizophrenics: data from the Maternal and Child Health Handbook", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.617~620 (2005)
120. Preti A, "Perinatal complications, genetic risk and schizophrenia", Acta Psychiatr Scand, 97, pp.381~383 (1998)
121. McNeil TF, "Obstetric complications in histories of monozygotic twins discordant and concordant for schizophrenia", Acta Psychiatr Scand, 89, pp.196~204 (1994)
122. Feinberg I, "Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence", J Psychiatr Res, 17, pp.319~334 (1982)
123. Walker E, "Pubertal neurodevelopment and the emergence of psychotic symptoms", Schizophr Res, 54, pp.17~23 (2002)
124. Catts VS, "Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene", Schizophr Res, 41, pp.405~415 (2000)
125. Park JK, "Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients", Schizophr Res, 67, pp.71~74 (2004)
126. Cui DH, "The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia", Mol Psychiatry, 10, pp.669~677 (2005)
127. Morelli C, "Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors", Oncogene, 21, pp.7266~7276 (2002)
128. Britsch S, "The neuregulin-I", ErbB signaling system in development and disease, 2007, pp.190, 1~65
129. Falls DL, "Neuregulins: functions, forms, and signaling strategies", Exp Cell Res, 284, pp.14~30 (2003)
130. Bjarnadottir M, "Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+", - knock-outs compared with wild-type mice, 2007, pp.27, 4519~4529
131. Roesler R, "Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders", CNS Neurol Disord Drug Targets, 5, pp.197~204 (2006)
132. Olincy A, "Decreased bombesin peptide response to cigarette smoking in schizophrenia", Neuropsychopharmacology, 20, pp.52~59 (1999)
133. Kinkead B, "Neurotensin, schizophrenia, and antipsychotic drug action", Int Rev Neurobiol, 59, pp.327~349 (2004)
134. Perkins DO, "microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder", Genome Biol, 8, pp.R27~ (2007)
135. Riley DE, "Short tandem repeat (STR) replacements in UTRs and introns suggest an important role for certain STRs in gene expression and disease", Gene, 344, pp.203~211 (2005)
136. Juvonen H, "Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus", Arch Gen Psychiatry, 64, pp.894~899 (2007)
137. Mors O, "A population-based register study of the association between schizophrenia and rheumatoid arthritis", Schizophr Res, 40, pp.67~74 (1999)
138. Torrey EF, "The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both", Brain Behav Immun, 15, pp.401~410 (2001)
139. Klimkeit EI, "Anomalous lateralisation in neurodevelopmental disorders", Cortex, 42, pp.113~116 (2006)
140. Preti A, "Mixed-handedness is associated with the reporting of psychotic-like beliefs in a non-clinical Italian sample", Schizophr Res, 92, pp.15~23 (2007)
141. Preti A, "Mixed handedness prevails among children and adolescents with infantile asthma and diabetes", Pediatr Allergy Immunol, 19, pp.769~772 (2008)
142. Strous RD, "Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited", J Autoimmun, 27, pp.71~80 (2006)
143. Yovel G, "Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking", Brain Behav Immun, 14, pp.153~169 (2000)
144. Peebles KA, "Inflammation and lung carcinogenesis: applying findings in prevention and treatment", Expert Rev Anticancer Ther, 7, pp.1405~1421 (2007)
145. Rasmussen HB, "Association between the CCR5 32-bp deletion allele and late onset of schizophrenia", Am J Psychiatry, 163, pp.507~511 (2006)
146. St-Gelais F, "The role of neurotensin in central nervous system pathophysiology: what is the evidence", J Psychiatry Neurosci, 31, pp.229~245 (2006)
147. Geroldi D, "Schizophrenia and cancer risk: can the CCR5-delta 32 chemokine receptor gene mutation play a role", Med Hypotheses, 67, pp.427~428 (2006)
148. Lasky JL, "Notch signaling, brain development, and human disease", Pediatr Res, 57, pp.104R~109R (2005)
149. Teunis MA, "Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system", FASEB J, 16, pp.1465~1457 (2002)
150. Hashimoto K, "Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals", Curr Pharm Des, 12, pp.3857~3876 (2006)
151. Nicodemus KK, "Serious obstetric complications interact with hypoxia-regulated", vascular-expression genes to influence schizophrenia risk, 2008, pp.13, 873~877
152. Schmidt-Kastner R, "Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia", Schizophr Res, 84, pp.253~271 (2006)
153. Williams GC, "Pleiotropy, natural selection, and the evolution of senescence", Evolution, 11, pp.398~411 (1957)
154. Crespi B, "Adaptive evolution of genes underlying schizophrenia", Proc Biol Sci, 274, pp.2801~2810 (2007)
155. Shi J, "Genetic associations with schizophrenia: meta- analyses of 12 candidate genes", Schizophr Res, 104, pp.96~107 (2008)
156. Jones RE, "Human Reproductive Biology" (2006), Academic Press
157. Crow TJ, "The ‘big bang’ theory of the origin of psychosis and the faculty of language", Schizophr Res, 102, pp.31~52 (2008)
158. Dalziel SR, "Psychological functioning and health-related quality of life in adulthood after preterm birth", Dev Med Child Neurol, 49, pp.597~602 (2007)
159. Obel C, "Psychological factors in pregnancy and mixed-handedness in the offspring", Dev Med Child Neurol, 45, pp.557~561 (2003)
160. O’Callaghan MJ, "The prevalence and origins of left hand preference in high risk infants, and its implications for intellectual, motor and behavioural performance at four and six years", Cortex, 29, pp.617~627 (1993)
161. Dragovic M, "Handedness in schizophrenia: a quantitative review of evidence", Acta Psychiatr Scand, 111, pp.410~419 (2005)
162. Sommer I, "Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis", Br J Psychiatry, 178, pp.344~351 (2001)
163. Panksepp J, "The seven sins of evolutionary psychology", Evolution Cognition, 6, pp.108~131 (2000)
164. Burdick KE, "Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability", Am J Psychiatry, 167, pp.436~443 (2010)
165. Rybakowski JK, "Matrix metalloproteinase-9 (MMP9)-a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders", Cardiovasc Psychiatry Neurol, 2009, pp.904836~ (2009)
166. Walsh T, "Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia", Science, 320, pp.539~543 (2008)
167. Sun J, "Schizophrenia gene networks and pathways and their applications for novel candidate gene selection", PLoS One, 5, pp.e11351~ (2010)
168. Lewis G, "Schizophrenia and city life", Lancet, 340, pp.137~140 (1992)
169. Pedersen CB, "Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk", Arch Gen Psychiatry, 58, pp.1039~1046 (2001)
170. Kirkbride JB, "Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study", Arch Gen Psychiatry, 63, pp.250~258 (2006)
171. Boydell J, "Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment", BMJ, 323, pp.1336~1338 (2001)
172. Cantor-Graae E, "Schizophrenia and migration: a meta-analysis and review", Am J Psychiatry, 162, pp.12~24 (2005)
173. Fearon P, "Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study", Incidence of Psychol Med, 36, pp.1541~1550 (2006)
174. McGrath JJ, "Season of birth and schizophrenia: a systematic review and meta-analysis of data from the Southern Hemisphere", Schizophr Res, 35, pp.237~242 (1999)
175. Davies G, "A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia", Schizophr Bull, 29, pp.587~593 (2003)
176. Mednick SA, "Adult schizophrenia following prenatal exposure to an influenza epidemic", Arch Gen Psychiatry, 45, pp.189~192 (1988)
177. Bagalkote H, "Maternal influenza and schizophrenia in the offspring", Int J Ment Health, 29, pp.3~21 (2001)
178. Brown AS, "Serologic evidence of prenatal influenza in the etiology of schizophrenia", Arch Gen Psychiatry, 61, pp.774~780 (2004)
179. Brown AS, "Nonaffective psychosis after prenatal exposure to rubella", Am J Psychiatry, 157, pp.438~443 (2000)
180. Suvisaari J, "Association between prenatal exposure to poliovirus infection and adult schizophrenia", Am J Psychiatry, 156, pp.1100~1102 (1999)
181. Brown AS, "Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring", Am J Psychiatry, 162, pp.767~773 (2005)
182. Torrey EF, "Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis", Schizophr Bull, 33, pp.729~736 (2007)
183. Koponen H, "Childhood central nervous system infections and risk for schizophrenia", Eur Arch Psychiatry Clin Neurosci, 254, pp.9~13 (2004)
184. Dalman C, "Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects", Am J Psychiatry, 165, pp.59~65 (2008)
185. Susser ES, "Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945", Arch Gen Psychiatry, 49, pp.983~988 (1992)
186. St Clair D, "Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961", JAMA, 294, pp.557~562 (2005)
187. Brown AS, "Prenatal nutritional deficiency and risk of adult schizophrenia", Schizophr Bull, 34, pp.1054~1063 (2008)
188. Selten JP, "Psychotic illness after prenatal exposure to the 1953 Dutch Flood Disaster", Schizophr Res, 35, pp.243~245 (1999)
189. Mäki P, "Schizophrenia in the offspring of antenatally depressed mothers: a 31-year follow- up of the Northern Finland 1966 Birth Cohort", Schizophr Res, 66, pp.79~81 (2004)
190. Myhrman A, "Unwantedness of a pregnancy and schizophrenia in the child", Br J Psychiatry, 169, pp.637~640 (1996)
191. van Os J, "Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands", Br J Psychiatry, 172, pp.324~326 (1998)
192. Beydoun H, "Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence", Paediatr Perinat Epidemiol, 22, pp.438~466 (2008)
193. Rosso IM, "Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort", Am J Psychiatry, 157, pp.801~807 (2000)
194. Zornberg GL, "Hypoxic-ischemia-related fetal", neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study, 2000, pp.157, 196~202
195. Rifkin L, "Low birth weight and schizophrenia", Br J Psychiatry, 165, pp.357~362 (1994)
196. Dalman C, "Signs of asphyxia at birth and risk of schizophrenia. Population-based casecontrol study", Br J Psychiatry, 179, pp.403~408 (2001)
197. Wahlbeck K, "Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood", Arch Gen Psychiatry, 58, pp.48~52 (2001)
198. Buka SL, "Pregnancy", delivery complications and psychiatric diagnosis. A prospective study, 1993, pp.50, 151~156
199. Dalman C, "Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort", Arch Gen Psychiatry, 56, pp.234~240 (1999)
200. Cardno AG, "Heritability estimates for psychotic disorders: the Maudsley twin psychosis series", Arch Gen Psychiatry, 56, pp.162~168 (1999)
201. Kringlen E, "Twin studies in schizophrenia with special emphasis on concordance figures", Am J Med Genet, 97, pp.4~11 (2000)
202. Davis KL, "Dopamine in schizophrenia: a review and reconceptualization", Am J Psychiatry, 148, pp.1474~1486 (1991)
203. Kapur S, "Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia", Am J Psychiatry, 160, pp.13~23 (2003)
204. Gracie A, "The association between traumatic experience, paranoia and hallucinations: a test of the predictions of psychological models", Acta Psychiatr Scand, 116, pp.280~289 (2007)
205. Scott J, "Association between trauma exposure and delusional experiences in a large community- based sample", Br J Psychiatry, 190, pp.339~343 (2007)
206. D’Souza DC, "Cannabinoids and psychosis", Int Rev Neurobiol, 78, pp.289~326 (2007)

관련 논문AI추천